1994
DOI: 10.1164/ajrccm.150.3.8087347
|View full text |Cite
|
Sign up to set email alerts
|

Role of cardiopulmonary exercise testing and the criteria used to determine disability in patients with severe chronic obstructive pulmonary disease.

Abstract: The aim of this study was to evaluate the precision and variability with which resting pulmonary function tests (resting PFTs) can be used to predict the capacity in exercise, and the usefulness of the different measurements of pulmonary function in the evaluation of impairment/disability in patients with chronic obstructive pulmonary disease (COPD). We studied 78 patients with stabilized COPD (FEV1 45.1 +/- 17.1%). Of these, 39 suffered severe impairment according to the resting PFTs. Both the group with seve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
25
2
2

Year Published

1997
1997
2013
2013

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(30 citation statements)
references
References 0 publications
1
25
2
2
Order By: Relevance
“…This is especially true in patients in whom exercise is limited by lung function [3][4][5][6][7][8][9]. This is not only because exertional dyspnoea is not well predicted from pul monary function, but also because many patients with lung disease stop exercising owing to fatigue, chest pain and leg discomfort rather than dyspnoea [3], For these reasons and because measures of health-related quality of life correlate better with exercise tolerance than with either spirometry or oxygenation [9], CPET is a useful tool in the integrated evaluation of common problems such as unexplained dyspnoea on exertion and limita tion of exercise tolerance [39,40].…”
Section: Assessing Exercise Tolerance and Potential Limiting Fa C Torsmentioning
confidence: 99%
See 1 more Smart Citation
“…This is especially true in patients in whom exercise is limited by lung function [3][4][5][6][7][8][9]. This is not only because exertional dyspnoea is not well predicted from pul monary function, but also because many patients with lung disease stop exercising owing to fatigue, chest pain and leg discomfort rather than dyspnoea [3], For these reasons and because measures of health-related quality of life correlate better with exercise tolerance than with either spirometry or oxygenation [9], CPET is a useful tool in the integrated evaluation of common problems such as unexplained dyspnoea on exertion and limita tion of exercise tolerance [39,40].…”
Section: Assessing Exercise Tolerance and Potential Limiting Fa C Torsmentioning
confidence: 99%
“…CPET is an area of growing interest in pulmonary medicine for three major reasons: 1) its large potential clinical applicability (see section on Indications); 2) the essentially noninvasive nature of the testing; and 3) pro vision of information that cannot be obtained through conventional lung function testing performed at rest [3][4][5][6][7][8][9]. During the past few years, two factors have con tributed to the current level of interest in CPET in pul monary medicine.…”
mentioning
confidence: 99%
“…Subjects with chronic obstructive pulmonary disease (COPD) have reduced maximal ventilation at peak exercise [1] and stop exercising despite significant cardiovascular reserve [2]. The application of noninvasive intermittent positivepressure ventilation (NiIPPV) during exercise may increase ventilation, and reduce breathlessness [3], inspiratory effort [3,4] and loading of the inspiratory muscles [5].…”
mentioning
confidence: 99%
“…The haemodynamic response to exercise in chronic obstructive pulmonary disease: assessment by impedance cardiography In most patients with chronic obstructive pulmonary disease (COPD) maximal exercise capacity is diminished, but pulmonary function tests provide a poor prediction of peak exercise oxygen consumption (V 'O 2 ) [1][2][3]. An aberrant haemodynamic response may contribute to the decreased exercise tolerance [4,5].…”
mentioning
confidence: 99%